Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
NCT00499954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2007-07-12
Summary
This is a mono-centre trial performed at the Center for Clinical Research at the Medical University Graz. There will be a screening information and a study visit.In the study visit arterialized venous blood glucose values will be monitored and subcutaneous sampling of interstitial fluid (ISF) with microdialysis for glucose determination will be performed. Additionally to the laboratory analysis of the subcutaneous glucose samples, the glucose will be measured with extracorporeal on-line sensors and two marketed devices (Guardian RT and Glucoday S).The study visit will last 30 hours starting with the insertion of microdialysis catheters in the abdominal subcutaneous tissue and the insertion of the catheters for the Glucoday S system and Guardian RT system. The primary hypothesis of the study is: Interstitial fluid glucose concentration profiles correlate to the arterialized venous blood glucose concentration profile in type 1 diabetic subjects.
Conditions
Interventions
- PROCEDURE
-
Microdialysis
- DEVICE
-
Guardian RT
- DEVICE
-
Glucoday S
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Thomas R Pieber, MD · Medical University Graz, Graz, Austria
Eligibility
- Min Age
- 19 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
Countries
- Austria
Study Locations
More Related Trials
-
Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
NCT02359617 ·Status: COMPLETED ·Phase: NA
-
Closed Loop Insulin Therapy in Type 1 Diabetics Based on Blood Microdialysis, Online Sensors and an eMPC Algorithm
NCT00535483 ·Status: COMPLETED
-
Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
NCT07242664 ·Status: RECRUITING ·Phase: PHASE1
-
A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
NCT07160816 ·Status: RECRUITING
-
Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
NCT02733991 ·Status: COMPLETED ·Phase: NA
-
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02465411 ·Status: COMPLETED ·Phase: NA
-
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
NCT05641753 ·Status: RECRUITING ·Phase: PHASE4
-
The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT
NCT00111228 ·Status: COMPLETED ·Phase: NA
-
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
NCT01755416 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Functional Insulinotherapy on Blood Glucose Variability Indicators in Patients With Type 1 Diabetes
NCT00973492 ·Status: UNKNOWN
-
Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period
NCT01712594 ·Status: COMPLETED ·Phase: NA
-
Smart MDI Study (CIP343)
NCT06645834 ·Status: COMPLETED ·Phase: NA
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
NCT01666028 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia
NCT02028078 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children
NCT02179281 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of an Integrated Sensor and Infusion Set
NCT01770561 ·Status: COMPLETED ·Phase: NA
-
The Impact of Daily Carbohydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-loop System
NCT05866900 ·Status: UNKNOWN
-
Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
NCT02733211 ·Status: WITHDRAWN ·Phase: NA
-
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
NCT01784211 ·Status: COMPLETED ·Phase: PHASE1
-
Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)
NCT04016662 ·Status: COMPLETED ·Phase: PHASE4
-
Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)
NCT02636491 ·Status: COMPLETED ·Phase: NA
-
Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes
NCT01713348 ·Status: COMPLETED ·Phase: PHASE4
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
NCT02846831 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
NCT02612844 ·Status: COMPLETED ·Phase: PHASE1